Helen Louise Collins

Chief Medical Officer, Enliven Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$5.6M

Companies

Latest trade

Oct 19, 2026

Companies

Enliven Therapeutics, Inc.Chief Medical Officer −$5.6M

Trades

ELVN Sold 5,000 shares at $38.47 · planned $0.2M Oct 19

ELVN Sold 5,000 shares at $50.35 · planned $0.3M Sep 17

ELVN Sold 5,000 shares at $58.59 · planned $0.3M Aug 17

ELVN Sold 5,000 shares at $52.67 · planned $0.3M Jul 17

ELVN Sold 5,000 shares at $43.80 · planned $0.2M Jun 17

ELVN Sold 5,000 shares at $39.79 · planned $0.2M May 18

ELVN Sold 5,000 shares at $47.67 · planned $0.2M Apr 17

ELVN Sold 40,000 shares at $35.10 · planned $1.4M Mar 25

ELVN Sold 5,000 shares at $27.76 · planned $0.1M Mar 17

ELVN Sold 10,129 shares at $30.19 · planned $0.3M Mar 10

ELVN Sold 29,871 shares at $30.02 · planned $0.9M Mar 9

ELVN Sold 45,000 shares at $26.17 · planned $1.2M Feb 17

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.